Cardio Exam 2: Dyslipidemia Elsaid WRITTEN NOTES

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/38

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 8:31 AM on 6/29/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

39 Terms

1
New cards

What are the dyslipidemia meds/classes? (9)

Ezetimibe, PCSK9 Inhibitors, Inclisiran, Bempedoic Acid, BAS, Fenofibrate, Gemfibrozil, Nicotinic Acid, and Omega-3 FAs

2
New cards

Ezetimibe MOA?

Inhibits cholesterol absorption in the small intestines

3
New cards

Ezetimibe other MOA info?

NPC1L1 (becomes inhibited) = cholesterol uptake

4
New cards

NPC1L1 is a _____.

sterol transporter

5
New cards

Ezetimibe effects?

Decreases cholesterol to the liver, increases plasma cholesterol’s clearance, and minimal GI effects

6
New cards

Ezetimibe other info?

Efficacy: Atorvastatin (80 mg) = Atorvastatin/Ezetimibe (20/10 mg)

7
New cards

What are the PCSK9 Inhibitor drugs?

Alirocumab and Evolocumab

8
New cards

Alirocumab is a _____ drug.

PCSK9 Inhibitor

9
New cards

Evolocumab is a _____ drug.

PCSK9 Inhibitor

10
New cards

PCSK9 Inhibitor MOA?

Chaperone proteins made in the liver and are metabolized to small peptides and AAs

11
New cards

PCSK9 Inhibitor specific MOA?

Clears PCSK9 protein and LDL-C

12
New cards

PCSK9 Inhibitor Formulation + Frequency?

SQ injection every 2-4 weeks

13
New cards

PCSK9 Inhibitor other info?

Fully humanized mAbs and no renal elimination

14
New cards

Inclisiran MOA sequence?

Passenger Strand: 2 RNA , then GalNAc, then targeted hepatic delivery
Hepatocyte: Passenger strand dissociates from guide strand. then guide strand assembles and binds to RISC, then, RISC-guided strand binds PCSK9 mRNA and blocks translation, then degradation of PCSK9 mRNA, then no PCSK9

KNOW

15
New cards

Bempedoic Acid MOA?

ATL Inhibitor

16
New cards

ATL stands for….

Adenosine Triphosphate-Citrate Lyase

17
New cards

Bempedoic Acid MOA sequence?

Inhibits cholesterol synthesis in the liver upstream of HMG-CoA Reductase, then increases LDL receptors, then decreases plasma LDL-C

18
New cards

Bempedoic Acid when Activated?

Inhibits ACL enzyme and decreases cholesterol synthesis in hepatocytes

19
New cards

Bempedoic Acid other info?

Prodrug activated by ACSVL1 in liver, there’s no ACSVL1 enzyme in myocytes, and used for adults with HeFH or established ASCVD

20
New cards

BAS are _____.

resins

21
New cards

BAS MOA?

Increases hepatic uptake of serum cholesterol by creating an insoluble complex with bile acids and salts that prevents their reabsorption from the intestine

22
New cards

BAS secretion/reabsorption info?

>90% of Bile Acids secreted into intestine are reabsorbed

23
New cards

BAS Effects?

GI adverse effects such as constipation, bloating, gas, and nausea

24
New cards

BAS C/I?

TG >300 mg/dL caused by pancreatitis

25
New cards

How are bile acids made?

Increase BA excretion and Hepatic conversion of cholesterol

26
New cards

Fenofibrate MOA sequence?

Nucleus to PPAR Nuclear Factor to Activation to Increasing LPL to hydrolyzed TG levels to Lipoprotein metabolism

27
New cards

Fenofibrate MOA sequence shortened?

Liver to VLDL to apoC-III to LPL to LDL

28
New cards

LPL = _____, which decreases _____

LPL is in the _____

Fenofibrate, TGs, endothelium of blood vessels

29
New cards

Gemfibrozil vs Fenofibrate?

Same efficacy as Fenofibrate with no statins, but Fenofibrate preferred in combo with statins

30
New cards

Nicotinic Acid MOA?

Inhibition of free FA release from adipose tissue that increases LPL activity and niacin inhibits TGs to FAs to decreases VLDL/LDL

31
New cards

Nicotinic Acid shortened MOA?

Decreased hepatic production of VLDL and apoB

32
New cards

Nicotinic Acid Effects?

Too many adverse effects such as Flushing/Vasodilation, leading to increased HR and reflex tachycardia

33
New cards

Omega-3 FAs MOA?

DGAT inhibits TG-synthesizing enzymes, which increases LPL and decreases hepatic synthesis and secretion of VLDL particles

34
New cards

Omega-3 FAs ingredients?

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)

35
New cards

Omega-3 FAs other info?

Rx (NOT to OTC med)

36
New cards

High-Intensity Statin MOA?

Blocks cholesterol synthesis and increases HDL to take cholesterol plaques back to the liver

37
New cards

Statins = Pleotropic Effects?

  • Decreased _____ and _____ risk

  • Inhibition of _____ and/or _____ generation

  • Stabilize atherosclerotic _____

inflammation, blood clot formation, platelet aggregation, thrombin, plaques

38
New cards

TG-Lowering Agents?

Lovaza (ethyl ester), Epanova (FA), Vascepa, Gemfibrozol, Fenofibrate, and Niacin

39
New cards

REMEMBER

  • _____ = HMG CoA Reductase inhibitors

  • _____ = ACL inhibitor

  • _____ = PCSK9 Inhibiting Agents

  • _____ = Generics of BAS

  • _____ = Brands of BAS

  • _____ = Cholesterol Absorption Inhibitor

  • _____ = TG-Lowering Agents

  • _____ = EPA+DHA Ethyl Ester

  • _____ = EPA+DHA FA

  • _____ = Icosapent Ethyl

Statins

Bempedoic Acid

-rocumab and Inclisiran

Colesevelam, Colestipol, and Cholestyramine

Welchol, Colestid, and Questran

Ezetimibe

Fibrates, Omega-3 FAs, and Niacin

Lovaza

Epanova

Vascepa